Phase III trial of addition of adjuvant chemotherapy to standard chemoradiation as primary treatment for cervical cancer

See ANZCTR for full trial details >

 

Trial Summary:

The OUTBACK trial is designed for women with locally advanced cervical cancer suitable for primary treatment with chemoradiation. Its aim is to determine whether addition of adjuvant chemotherapy to standard cisplatin-based chemoradiation improves overall survival.

Supported By:

 

Eligibility:

Women with locally advanced cervix cancer

Registration ID:

ACTRN12610000732088

Participation:

International

Australian Lead Group:

ANZGOG

Status:

open

Activation Date:

10/03/2011

Chairs:

Prof Linda Mileshkin (Australia)

Contact:

outback.study@sydney.edu.au